A single-center retrospective study analyzing COVID-19 vaccine immunogenicity among CD19 receptor T-cell (CAR-T) therapy
Latest Information Update: 03 Feb 2023
Price :
$35 *
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 03 Feb 2023 New trial record